Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions

开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策

基本信息

  • 批准号:
    10186503
  • 负责人:
  • 金额:
    --
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-02-01 至 2021-09-30
  • 项目状态:
    已结题

项目摘要

Ignoring life expectancy can lead to poor clinical decisions. Healthy older adults who could benefit from screening have low screening rates. Older adults with dementia or metastatic cancer are screened for slow- growing cancers that are unlikely to cause symptoms but may lead to distress from false-positive results, invasive work-ups and treatments. Life expectancy calculators offer the possibility of moving beyond arbitrary age-based cutoffs to more rational life expectancy based decision-making, incorporating age as well as other factors known to predict mortality such as comorbidities, demographics, laboratory results and pharmacy data. The objectives of the study are to (a) develop and validate a 10-year life expectancy calculator using 2005 VA electronic data (demographics, comorbidities, laboratory results and pharmacy records); (b) develop and validate an Augmented life expectancy calculator that adds 2009 functional assessments (Activities of Daily Living or ADL and Instrumental Activities of Daily Living or IADL assessments) to the other risk factors and determine whether the addition of ADL and IADL data lead to improved discrimination; ); (c) develop and validate a VA-Medicare life expectancy calculator that adds 2009 Medicare data to the other risk factors and determine whether the addition of Medicare data lead to improved discrimination; (d) apply the life expectancy calculator to a national VA cohort to determine the proportion of colorectal cancer (CRC) screening that occurs in veterans with limited life expectancy (<25% likelihood of life expectancy of 10+ years) and extended life expectancy (>75% likelihood of life expectancy of 10+ years) in both veterans within the recommended age (50-75) for CRC screening as well as veterans at more advanced age (76-85) when screening is not routinely recommended. By developing and validating a VA electronic data driven life expectancy calculator, this project will determine the rates of potentially inappropriate CRC overscreening in age-appropriate veterans (age 50-75) with a limited life expectancy (<25% likelihood of life expectancy 10+ years). Conversely, this project will also identify potentially inappropriate CRC underscreening in veterans beyond the recommend age for screening (age 76-85) with an extended life expectancy (>75% likelihood of life expectancy of 10+ years). This work will provide the critical foundation for an intervention to improve the targeting of CRC screening will estimate an individual veterans' life expectancy to 1) suppress CRC screening clinical reminders for patients with limited life expectancy (age 50-75) or 2) trigger CRC screening clinical reminders for patients with extended life expectancy (age 76-85). Further, accurate life expectancy estimates could also be utilized to individualize other prevention decisions that have a long time to benefit, such as breast cancer screening and intensive glycemic control. Thus, this work would be another way that the VA would become a Learning Healthcare System that uses clinical data to individualize veterans' prevention decisions and inform system-wide decisions regarding prevention clinical alerts.
忽视预期寿命可能会导致糟糕的临床决策。健康的老年人可以受益于 筛查的筛查率很低。患有痴呆症或转移性癌症的老年人接受慢性病筛查 生长中的癌症不太可能引起症状,但可能会因假阳性结果而导致痛苦, 侵入性检查和治疗。预期寿命计算器提供了超越随意的可能性 基于年龄的截止时间,以更合理的预期寿命为基础的决策,包括年龄和其他 已知的预测死亡率的因素,如合并症、人口统计学、实验室结果和药房数据。 这项研究的目标是:(A)开发和验证使用以下技术的10年预期寿命计算器 2005年退伍军人管理局电子数据(人口统计、合并症、实验室结果和药房记录);(B)开发 并验证增加的预期寿命计算器,该计算器添加了2009年的功能评估(活动 日常生活或日常生活能力或工具性活动或IADL评估)对其他危险因素的影响 并确定增加ADL和IADL数据是否会改善歧视;);(C)制定和 验证VA-Medicare预期寿命计算器,该计算器将2009年的Medicare数据添加到其他风险因素和 确定增加医疗保险数据是否导致改善歧视;(D)适用预期寿命 用于确定发生的结直肠癌(CRC)筛查比例的国家VA队列计算器 对于预期寿命有限(预期寿命超过10年的可能性为25%)和延长寿命的退伍军人 两名退伍军人在推荐年龄内的预期寿命(预期寿命超过10年的可能性为75%) (50-75)用于结直肠癌筛查,以及年龄较高的退伍军人(76-85岁),当筛查不是常规检查时 推荐的。 通过开发和验证退伍军人电子数据驱动的预期寿命计算器,该项目将 确定适龄退伍军人(50-75岁)可能不适当的结直肠癌过度筛查的比率 预期寿命有限(预期寿命10年以上的可能性为25%)。反过来,这个项目也将 确定超过推荐筛查年龄的退伍军人中可能不适当的结直肠癌筛查不足 (76-85岁)预期寿命延长(预期寿命超过10岁的可能性为75%)。这项工作将 为改善针对结直肠癌筛查的干预措施提供关键基础将估计 退伍军人个人预期寿命1)抑制对有限寿命患者的CRC筛查临床提醒 预期(50-75岁)或2岁)为延长生命的患者触发CRC筛查临床提醒 预期(76-85岁)。此外,准确的预期寿命估计也可以用来个性化 其他长期受益的预防决策,如乳腺癌筛查和强化治疗 血糖控制。因此,这项工作将是退伍军人管理局成为学习型医疗保健的另一种方式 使用临床数据使退伍军人的预防决策个人化并为全系统决策提供信息的系统 关于预防和临床警报。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sei Lee其他文献

Sei Lee的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Sei Lee', 18)}}的其他基金

Prognostic Indices for Hospitalized Older Adults with and without Alzheimer’s Disease and Related Dementias
患有或不患有阿尔茨海默病和相关痴呆症的住院老年人的预后指数
  • 批准号:
    10740664
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
  • 批准号:
    9953776
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
  • 批准号:
    10328473
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Improving Care for Nursing Home residents with Diabetes and Cognitive Impairment
改善对患有糖尿病和认知障碍的疗养院居民的护理
  • 批准号:
    10616657
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Prognostic calculators for patients with Alzheimers disease and related dementias
阿尔茨海默病和相关痴呆症患者的预后计算器
  • 批准号:
    9912083
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Prognostic calculators for patients with Alzheimers disease and related dementias
阿尔茨海默病和相关痴呆症患者的预后计算器
  • 批准号:
    9762780
  • 财政年份:
    2018
  • 资助金额:
    --
  • 项目类别:
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
  • 批准号:
    10308527
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Development and Validation of 10-Year Life Expectancy Calculators to Individualize Veterans’ Prevention Decisions
开发和验证 10 年预期寿命计算器,以实现退伍军人的个性化预防决策
  • 批准号:
    9757611
  • 财政年份:
    2017
  • 资助金额:
    --
  • 项目类别:
Developing prognostic models for life expectancy and geriatric outcomes
开发预期寿命和老年结局的预后模型
  • 批准号:
    9067881
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:
Developing prognostic models for life expectancy and geriatric outcomes
开发预期寿命和老年结局的预后模型
  • 批准号:
    9390251
  • 财政年份:
    2015
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了